HBCM
CPIX icon

Heron Bay Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Heron Bay Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,189
Closed -$116K – 87
2025
Q4 		$116K Sell
29,189
-2,475
-8% -$7.33K 0.02% 100
2025
Q3 		$98.8K Sell
31,664
-1,587
-5% -$5.27K 0.02% 102
2025
Q2 		$111K Buy
+33,251
New +$158K 0.02% 99

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Heron Bay Capital Management's CPIX Position: Q1 2026 in Review

Heron Bay Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2026, closing a stake of 29,189 shares — an estimated $116K sold.

Heron Bay Capital Management first reported a position in CPIX in Q2 2025 and held it in 3 quarters. The position peaked at $116K in Q4 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Heron Bay Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Heron Bay Capital Management sold 29,189 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $116K.
  • Heron Bay Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • Heron Bay Capital Management's Cumberland Pharmaceuticals position peaked at $116K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Heron Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.